Selective and sensitive monitoring of caspase-1 activity by a novel bioluminescent activity-based probe

Chemistry and Biology

Volumn 17, Issue 9, 2010, Pages 999-1007

  Kindermann, Maik ^a   Roschitzki Voser, Heidi ^b   Cagli, Dejan ^c   Repnik, Urka ^c   Miniejew, Catherine ^a   Mittl, Peer R E ^b   Kosec, Gregor ^c   Grütter, Markus G ^b   Turk, Boris ^c   Wendt, K Ulrich ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CM 269; CYSTEINE PROTEINASE INHIBITOR; DRUG DERIVATIVE; FLUORESCENT DYE; FUSED HETEROCYCLIC RINGS; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN PRECURSOR; RECOMBINANT PROTEIN;

ARTICLE; CHEMISTRY; DRUG ANTAGONISM; ENZYME SPECIFICITY; GENETICS; HUMAN; LUMINESCENCE; METABOLISM; METHODOLOGY; SYNTHESIS; TUMOR CELL LINE;

ASPARTIC ACID; BICYCLO COMPOUNDS, HETEROCYCLIC; CASPASE 1; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; FLUORESCENT DYES; HUMANS; INTERLEUKIN-18; INTERLEUKIN-1BETA; LUMINESCENT MEASUREMENTS; PROTEIN PRECURSORS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

EID: 77956972823     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2010.07.011     Document Type: Article

References (49)

1. E.S. Alnemri, D.J. Livingston, D.W. Nicholson, G. Salvesen, N.A. Thornberry, W.W. Wong, and J. Yuan Human ICE/CED-3 protease nomenclature Cell 87 1996 171
2. J.M. Ayala, T.T. Yamin, L.A. Egger, J. Chin, M.J. Kostura, and D.K. Miller IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor J. Immunol. 153 1994 2592 2599
3. B.C. Baliga, S.H. Read, and S. Kumar The biochemical mechanism of caspase-2 activation Cell Death Differ. 11 2004 1234 1241
4. A. Baruch, D.A. Jeffery, and M. Bogyo Enzyme activity - it's all about image Trends Cell Biol. 14 2004 29 35
5. R.A. Black, S.R. Kronheim, and P.R. Sleath Activation of interleukin-1 beta by a co-induced protease FEBS Lett. 247 1989 386 390
6. G. Blum Use of fluorescent imaging to investigate pathological protease activity Curr. Opin. Drug Discov. Devel. 11 2008 708 716
7. G. Blum, S.R. Mullins, K. Keren, M. Fonovic, C. Jedeszko, M.J. Rice, B.F. Sloane, and M. Bogyo Dynamic imaging of protease activity with fluorescently quenched activity-based probes Nat. Chem. Biol. 1 2005 203 209
8. G. Blum, G. von Degenfeld, M.J. Merchant, H.M. Blau, and M. Bogyo Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes Nat. Chem. Biol. 3 2007 668 677
9. K.M. Boatright, M. Renatus, F.L. Scott, S. Sperandio, H. Shin, I.M. Pedersen, J.E. Ricci, W.A. Edris, D.P. Sutherlin, and D.R. Green A unified model for apical caspase activation Mol. Cell 11 2003 529 541
10. S. Cornelis, K. Kersse, N. Festjens, M. Lamkanfi, and P. Vandenabeele Inflammatory caspases: targets for novel therapies Curr. Pharm. Des. 13 2007 367 385
11. C.A. Dinarello Interleukin-1 Cytokine Growth Factor Rev. 8 1997 253 265
12. C.A. Dinarello Interleukin-18 Methods 19 1999 121 132
13. M. Donepudi, A. Mac Sweeney, C. Briand, and M.G. Grutter Insights into the regulatory mechanism for caspase-8 activation Mol. Cell 11 2003 543 549
14. M.J. Evans, and B.F. Cravatt Mechanism-based profiling of enzyme families Chem. Rev. 106 2006 3279 3301
15. B. Faustin, L. Lartigue, J.M. Bruey, F. Luciano, E. Sergienko, B. Bailly-Maitre, N. Volkmann, D. Hanein, I. Rouiller, and J.C. Reed Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation Mol. Cell 25 2007 713 724
16. T. Fernandes-Alnemri, J.W. Yu, P. Datta, J. Wu, and E.S. Alnemri AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA Nature 458 2009 509 513
17. L. Franchi, T. Eigenbrod, R. Munoz-Planillo, and G. Nunez The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis Nat. Immunol. 10 2009 241 247
18. M. Garcia-Calvo, E.P. Peterson, B. Leiting, R. Ruel, D.W. Nicholson, and N.A. Thornberry Inhibition of human caspases by peptide-based and macromolecular inhibitors J. Biol. Chem. 273 1998 32608 32613
19. M. Garcia-Calvo, E.P. Peterson, D.M. Rasper, J.P. Vaillancourt, R. Zamboni, D.W. Nicholson, and N.A. Thornberry Purification and catalytic properties of human caspase family members Cell Death Differ. 6 1999 362 369
20. J. Grabarek, P. Amstad, and Z. Darzynkiewicz Use of fluorescently labeled caspase inhibitors as affinity labels to detect activated caspases Hum. Cell 15 2002 1 12
21. V.D. Joshi, D.V. Kalvakolanu, J.R. Hebel, J.D. Hasday, and A.S. Cross Role of caspase 1 in murine antibacterial host defenses and lethal endotoxemia Infect. Immun. 70 2002 6896 6903
22. N. Keller, M.G. Grutter, and O. Zerbe Studies of the molecular mechanism of caspase-8 activation by solution NMR Cell Death Differ. 17 2010 710 718
23. M.J. Kostura, M.J. Tocci, G. Limjuco, J. Chin, P. Cameron, A.G. Hillman, N.A. Chartrain, and J.A. Schmidt Identification of a monocyte specific pre-interleukin 1 beta convertase activity Proc. Natl. Acad. Sci. USA 86 1989 5227 5231
24. M. Lara-Tejero, F.S. Sutterwala, Y. Ogura, E.P. Grant, J. Bertin, A.J. Coyle, R.A. Flavell, and J.E. Galan Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis J. Exp. Med. 203 2006 1407 1412
25. S.D. Linton Caspase inhibitors: a pharmaceutical industry perspective Curr. Top. Med. Chem. 5 2005 1697 1717
26. F. Martinon, and J. Tschopp Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases Cell 117 2004 561 574
27. F. Martinon, K. Burns, and J. Tschopp The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta Mol. Cell 10 2002 417 426
28. F. Martinon, V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 440 2006 237 241
29. G.P. McStay, G.S. Salvesen, and D.R. Green Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways Cell Death Differ. 15 2008 322 331
30. V.B. Mehta, J. Hart, and M.D. Wewers ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage J. Biol. Chem. 276 2001 3820 3826
31. A. Oberst, C. Pop, A.G. Tremblay, V. Blais, J.B. Denault, G.S. Salvesen, and D.R. Green Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation J. Biol. Chem. 285 2010 16632 16642
32. N.A. Pereira, and Z. Song Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity Biochem. Biophys. Res. Commun. 377 2008 873 877
33. T.A. Rano, T. Timkey, E.P. Peterson, J. Rotonda, D.W. Nicholson, J.W. Becker, K.T. Chapman, and N.A. Thornberry A combinatorial approach for determining protease specificities: application to interleukin-1beta converting enzyme (ICE) Chem. Biol. 4 1997 149 155
34. J. Rozman-Pungerar, N. Kopitar-Jerala, M. Bogyo, D. Turk, O. Vasiljeva, I. Stefe, P. Vandenabeele, D. Bromme, V. Puizdar, and M. Fonović Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity Cell Death Differ. 10 2003 881 888
35. G.S. Salvesen, and V.M. Dixit Caspases: intracellular signaling by proteolysis Cell 91 1997 443 446
36. J.M. Scheer, M.J. Romanowski, and J.A. Wells A common allosteric site and mechanism in caspases Proc. Natl. Acad. Sci. USA 103 2006 7595 7600
37. A.M. Scott, and M. Saleh The inflammatory caspases: guardians against infections and sepsis Cell Death Differ. 14 2007 23 31
38. B. Siegmund, and M. Zeitz Pralnacasan (Vertex Pharmaceuticals) IDrugs 6 2003 154 158
39. S.M. Srinivasula, J.L. Poyet, M. Razmara, P. Datta, Z. Zhang, and E.S. Alnemri The PYRIN-CARD protein ASC is an activating adaptor for caspase-1 J. Biol. Chem. 277 2002 21119 21122
40. H.R. Stennicke, and G.S. Salvesen Caspases: preparation and characterization Methods 17 1999 313 319
41. N.A. Thornberry The caspase family of cysteine proteases Br. Med. Bull. 53 1997 478 490
42. N.A. Thornberry, H.G. Bull, J.R. Calaycay, K.T. Chapman, A.D. Howard, M.J. Kostura, D.K. Miller, S.M. Molineaux, J.R. Weidner, and J. Aunins A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes Nature 356 1992 768 774
43. N.A. Thornberry, T.A. Rano, E.P. Peterson, D.M. Rasper, T. Timkey, M. Garcia-Calvo, V.M. Houtzager, P.A. Nordstrom, S. Roy, and J.P. Vaillancourt A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis J. Biol. Chem. 272 1997 17907 17911
44. T. Troy, D. Jekic-McMullen, L. Sambucetti, and B. Rice Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models Mol. Imaging 3 2004 9 23
45. S. Tsuchiya, Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae, T. Konno, and K. Tada Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester Cancer Res. 42 1982 1530 1536
46. J. Wang, H.J. Chun, W. Wong, D.M. Spencer, and M.J. Lenardo Caspase-10 is an initiator caspase in death receptor signaling Proc. Natl. Acad. Sci. USA 98 2001 13884 13888
47. A. Watzke, G. Kosec, M. Kindermann, V. Jeske, H.P. Nestler, V. Turk, B. Turk, and K.U. Wendt Selective activity-based probes for cysteine cathepsins Angew. Chem. Int. Ed. Engl. 47 2008 406 409
48. J.H. Zhang, T.D. Chung, and K.R. Oldenburg A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screen. 4 1999 67 73
49. W. Zhou, C. Andrews, J. Liu, J.W. Shultz, M.P. Valley, J.J. Cali, E.M. Hawkins, D.H. Klaubert, R.F. Bulleit, and K.V. Wood Self-cleavable bioluminogenic luciferin phosphates as alkaline phosphatase reporters ChemBioChem 9 2008 714 718